Skip to Main Content

Paper Details

Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.
NPJ Precis Oncol
6
2023
BRCA1/2, GIST, GISTs, KIT, KIT/PDGFRA-wildtype GISTs, NF1, PDGFRA, SDHA, SDHB, SDHC, gastrointestinal stromal tumors, germline, hereditary cancer, patients, syndromic, syndromic features, tumor
Author NameAffiliation
Pier SelenicaMemorial Sloan Kettering Cancer Center
Michael F WalshMemorial Sloan Kettering Cancer Center
Chaitanya BandlamudiMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2